NCT00687037View on ClinicalTrials.gov

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

Cetylpyridinium chloride

Trial Locations (1)

Unknown

Sanofi-aventis, São Paulo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00687037 - Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power | Biotech Hunter | Biotech Hunter